287 related articles for article (PubMed ID: 23111358)
41. Comparison of 3 Ways of Dissecting the Pancreatoduodenectomy Specimen and Their Impact in the Lymph Node Count and the Lymph Node Metastatic Ratio.
Lino-Silva LS; Salcedo-Hernández RA; Segales-Rojas P; Zepeda-Najar C
Int J Surg Pathol; 2018 Dec; 26(8):707-713. PubMed ID: 29873282
[TBL] [Abstract][Full Text] [Related]
42. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
43. Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories.
Strobel O; Hinz U; Gluth A; Hank T; Hackert T; Bergmann F; Werner J; Büchler MW
Ann Surg; 2015 May; 261(5):961-9. PubMed ID: 24979603
[TBL] [Abstract][Full Text] [Related]
44. The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.
Showalter TN; Winter KA; Berger AC; Regine WF; Abrams RA; Safran H; Hoffman JP; Benson AB; MacDonald JS; Willett CG
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1328-35. PubMed ID: 20934270
[TBL] [Abstract][Full Text] [Related]
45. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.
Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Bui JL; Yuan C; Qian ZR; Babic A; Da Silva A; Nowak JA; Khalaf N; Brais LK; Welch MW; Zellers CL; Ng K; Chang DT; Miksad RA; Bullock AJ; Tseng JF; Swanson RS; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Hornick JL; Ogino S; Fuchs CS; Hezel AF; Koong AC; Wolpin BM
Br J Cancer; 2017 Dec; 117(12):1874-1882. PubMed ID: 28982112
[TBL] [Abstract][Full Text] [Related]
46. Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A strobe-compliant study.
Zheng ZJ; Wang MJ; Tan CL; Chen YH; Ping J; Liu XB
Medicine (Baltimore); 2020 Feb; 99(8):e19327. PubMed ID: 32080152
[TBL] [Abstract][Full Text] [Related]
47. Adequate lymph node examination is essential to ensure the prognostic value of the lymph node ratio in patients with stage III colorectal cancer.
Shimomura M; Ikeda S; Takakura Y; Kawaguchi Y; Tokunaga M; Egi H; Hinoi T; Okajima M; Ohdan H
Surg Today; 2011 Oct; 41(10):1370-9. PubMed ID: 21922359
[TBL] [Abstract][Full Text] [Related]
48. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
49. [Clinical value of lymph node dissection of No. 14cd during pancreaticoduodenectomy in patients with pancreatic head carcinoma].
Wu PF; Zhang K; Tian L; Yin J; Wei JS; Xi CH; Chen JM; Guo F; Lu ZP; Miao Y; Jiang KR
Zhonghua Wai Ke Za Zhi; 2023 Jul; 61(7):582-589. PubMed ID: 37402687
[No Abstract] [Full Text] [Related]
50. Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
Huang L; Jansen L; Balavarca Y; van der Geest L; Lemmens V; Koerkamp BG; van Santvoort HC; Grützmann R; Besselink MG; Schrotz-King P; Brenner H
Ann Surg; 2021 Dec; 274(6):e554-e563. PubMed ID: 31425290
[TBL] [Abstract][Full Text] [Related]
51. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer.
Hou Y; Wang X; Chen J
World J Surg Oncol; 2018 Oct; 16(1):198. PubMed ID: 30286762
[TBL] [Abstract][Full Text] [Related]
53. Assessment of the nodal status in ampullary carcinoma: the number of positive lymph nodes versus the lymph node ratio.
Sakata J; Shirai Y; Wakai T; Ajioka Y; Akazawa K; Hatakeyama K
World J Surg; 2011 Sep; 35(9):2118-24. PubMed ID: 21717240
[TBL] [Abstract][Full Text] [Related]
54. Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasis.
Jin S; Wang J; Shen Y; Gan H; Xu P; Wei Y; Wei J; Wu J; Wang B; Wang J; Yang C; Zhu Y; Ye D
Int Urol Nephrol; 2020 Jan; 52(1):87-95. PubMed ID: 31552575
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
[TBL] [Abstract][Full Text] [Related]
56. Nodal microinvolvement in patients with carcinoma of the papilla of vater receiving no adjuvant chemotherapy.
Bogoevski D; Chayeb H; Cataldegirmen G; Schurr PG; Kaifi JT; Mann O; Yekebas EF; Izbicki JR
J Gastrointest Surg; 2008 Nov; 12(11):1830-7; discussion 1837-8. PubMed ID: 18791769
[TBL] [Abstract][Full Text] [Related]
57. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
[TBL] [Abstract][Full Text] [Related]
58. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy.
Fischer LK; Katz MH; Lee SM; Liu L; Wang H; Varadhachary GR; Wolff RA; Lee JE; Maitra A; Roland CL; Fleming JB; Estrella J; Rashid A; Wang H
Histopathology; 2016 Jan; 68(2):210-20. PubMed ID: 25945396
[TBL] [Abstract][Full Text] [Related]
59. Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield.
Warschkow R; Tsai C; Köhn N; Erdem S; Schmied B; Nussbaum DP; Gloor B; Müller SA; Blazer D; Worni M
Langenbecks Arch Surg; 2020 Feb; 405(1):43-54. PubMed ID: 32040705
[TBL] [Abstract][Full Text] [Related]
60. Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio.
Asiyanbola B; Gleisner A; Herman JM; Choti MA; Wolfgang CL; Swartz M; Edil BH; Schulick RD; Cameron JL; Pawlik TM
J Gastrointest Surg; 2009 Apr; 13(4):752-9. PubMed ID: 19089517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
